At a glance
ClinicalIndex Comparison RecordN/ACompleted· 333 enrolled
Drug / intervention
Nellix Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prospective, Multicenter, Single Arm Safety and Effectiveness Study of Endovascular Abdominal Aortic Aneurysm Repair Using the Nellix® System: A Pivotal and Continued Access Study
In Brief
A clinical study evaluating Nellix System for Abdominal Aortic Aneurysm (AAA). Completed, enrolled 333 participants across 30 sites in 4 countries.
Detailed Summary
The objective of this study is to assess the safety and effectiveness of the Endologix Nellix® System for the endovascular repair of infrarenal abdominal aortic aneurysms (AAA).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAbdominal Aortic Aneurysm (AAA)
CountriesGermany, Netherlands, United Kingdom, United States
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedNov 2012
Enrollment StartDec 2013
Primary CompletionJun 2016
Study CompletionDec 2022
TodayJul 2026
First PostedNov 14, 2012
Enrollment StartDec 1, 2013
Primary CompletionJun 1, 2016
Study CompletionDec 1, 2022
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 13.6 years ago
Interventions
Nellix Systemdevice
Subjects in this study will receive a Nellix Endovascular Sealing System as part of their intervention.